{"id":398564,"date":"2020-12-11T23:49:11","date_gmt":"2020-12-12T04:49:11","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=398564"},"modified":"2020-12-11T23:49:11","modified_gmt":"2020-12-12T04:49:11","slug":"fedex-to-ship-first-wave-of-covid-19-vaccines-across-the-united-states","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fedex-to-ship-first-wave-of-covid-19-vaccines-across-the-united-states\/","title":{"rendered":"FedEx to Ship First Wave of COVID-19 Vaccines Across the United States"},"content":{"rendered":"

<\/p>\n

FedEx to Ship First Wave of COVID-19 Vaccines Across the United States <\/b><\/p>\n

Company to begin COVID-19 vaccine shipments for Pfizer, Inc. <\/i><\/p>\n

MEMPHIS, Tenn.–(BUSINESS WIRE<\/a>)–
\nFedEx Express, a subsidiary of FedEx Corp. (NYSE: FDX) and the world\u2019s largest express transportation company, announced today that operations are in motion to transport its first shipments of COVID-19 vaccines.\n<\/p>\n

\nFollowing the Food and Drug Administration\u2019s approval of Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine, FedEx Express will begin transport of the vaccine using its FedEx Priority Overnight\u00ae<\/sup> service supported by FedEx Priority Alert\u00ae<\/sup> advanced monitoring. After months of preparation and close planning with Pfizer, other healthcare companies, and federal and state officials, the first COVID-19 vaccines will move to dosing centers in the United States. Vaccine distribution will be balanced among major cargo carriers, and FedEx is working closely with healthcare customers to prepare for additional vaccine shipments and transportation of critical vaccine-related supplies.\n<\/p>\n

\nThe FedEx network is well-positioned to handle COVID-19 vaccine shipments around the world with temperature-control solutions, near real-time monitoring capabilities and a dedicated healthcare team to support the express transportation of vaccines and bioscience shipments.\n<\/p>\n

\n\u201cThis is among the most important work in the history of our company, and we\u2019re honored to be a part of the effort to help end this pandemic,\u201d said Raj Subramaniam, president and chief operating officer, FedEx Corp. \u201cI am immensely proud of our dedicated team members who continue to go above and beyond to help ensure the safe movement of these critical COVID-19 vaccines, especially during our busiest holiday shipping season to date. This is who we are and what we do at FedEx.\u201d\n<\/p>\n

\nTransportation of COVID-19 vaccines is the next phase of ongoing FedEx efforts to support pandemic relief around the world. FedEx has a long history of supporting relief efforts when disasters strike, using its network and expertise to deliver for good.\n<\/p>\n

\n\u201cWe are one of the few companies with the global network and capabilities to keep critical supply chains moving during this unprecedented time,\u201d said Don Colleran, president and chief executive officer, FedEx Express. \u201cSince the onset of the COVID-19 pandemic, FedEx has delivered more than 55 kilotons of personal protective equipment, including more than two billion face masks, and more than 9,600 humanitarian aid shipments around the globe.\u201d\n<\/p>\n

\nTo help reach underserved communities with the COVID-19 vaccine, FedEx has committed $4 million in cash and in-kind transportation support to several nonprofits serving communities in the U.S. and around the world. These include Direct Relief, International Medical Corps, and Heart to Heart International.\n<\/p>\n

\n\u201cTime-definite express transportation of critical shipments is exactly what our FedEx Express network was built to do when it launched in 1973,\u201d said Richard W. Smith, regional president of the Americas and executive vice president of global support, FedEx Express. \u201cAlmost five decades later, we are proving true to our founding mission by delivering critical COVID-19 vaccines.\u201d\n<\/p>\n

\n\u201cThis is a historic moment and represents a monumental feat for vaccine development and expedient deployment,\u201d said Mike McDermott, president, Pfizer Global Supply. \u201cOutstanding logistics is critical to get our products to those who need them across the country, and we\u2019re happy to partner with FedEx in this historic effort to save lives and put an end to the COVID-19 pandemic.\u201d\n<\/p>\n

\nAbout the technology:\n<\/p>\n

\nAt FedEx, the information about the package is as important as the package itself as it moves through the network. FedEx SenseAware ID, a Bluetooth low-energy sensor device, will be affixed to vaccine shipments, helping to ensure these temperature-sensitive deliveries move swiftly and safely through the FedEx Express U.S. network with FedEx Priority Overnight service. From origin to destination, dedicated FedEx Priority Alert customer support agents are using SenseAware monitoring technology to track the location of vaccine shipments in near real-time. This technology is complemented by the FedEx Surround platform, which leverages artificial intelligence and predictive tools to proactively monitor conditions surrounding the packages, allowing customer support agents to intervene if weather or traffic delays threaten to impede delivery times.\n<\/p>\n

\nQuick stats about the FedEx network:\n<\/p>\n